Panchsheel Organics Ltd

Panchsheel Organics Ltd., an Indore-based active pharmaceutical ingredients (API) manufacturer, reported deeply concerning Q4 FY26 results that sent the stock tumbling 19.72% to ₹115.60 following the announcement. Whilst net sales reached a quarterly high of ₹31.07 crores—up 16.24% sequentially and 9.52% year-on-year—net profit collapsed 46.40% quarter-on-quarter to ₹1.70 crores, the lowest quarterly profit in over two years. The ₹172-crore market cap company faces mounting operational challenges despite maintaining modest top-line growth.

Panchsheel Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a mixed quarterly performance for the period ending March 2026. While the company achieved its highest-ever quarterly net sales at ₹31.07 crores, key profitability metrics deteriorated sharply, signalling a negative financial trend reversal from the previous quarter.

Panchsheel Organics Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 31 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Panchsheel Organics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Panchsheel Organics Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 09 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Panchsheel Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive rating. This change comes amid a backdrop of mixed returns relative to the broader market and peers, prompting a reassessment of its price attractiveness based on key metrics such as P/E and P/BV ratios.

Panchsheel Organics Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, driven primarily by its improved price-to-earnings (P/E) and price-to-book value (P/BV) ratios. This revaluation comes amid a challenging market backdrop and a mixed performance relative to the broader Sensex index, prompting investors to reassess the stock’s price attractiveness within the Pharmaceuticals & Biotechnology sector.

Panchsheel Organics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 April 2026, providing investors with an up-to-date view of its performance and outlook.

Panchsheel Organics Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 April 2026, providing investors with an up-to-date view of its performance and outlook.

Panchsheel Organics Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.

A sharp decline in Panchsheel Organics Ltd has pushed the stock to a fresh 52-week low of Rs 89.35 on 30 Mar 2026, marking a significant 12.52% drop over the past two sessions amid heightened volatility and sector underperformance.

Panchsheel Organics Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 26 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

A sustained decline has pushed Panchsheel Organics Ltd to a fresh 52-week low of Rs 92 on 24 Mar 2026, marking a significant -37.49% drop over the past year and underscoring persistent headwinds for the micro-cap pharmaceutical player.

For the fifth consecutive session, Panchsheel Organics Ltd closed lower, breaching its 52-week low at Rs 92.25 on 23 Mar 2026, marking a sharp decline of 9.56% intraday and underperforming its sector by 3.58%.

Panchsheel Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.97 today, marking a significant decline amid broader market movements. The stock has underperformed its sector and benchmark indices, reflecting ongoing pressures on its valuation and performance metrics.

Panchsheel Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, touched a new 52-week low of Rs.98.25 today, marking a significant decline amid broader market weakness and persistent underperformance relative to benchmarks.

Panchsheel Organics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.